The Rationale for Early Diagnosis of Cancer: The Example of Breast Cancer

REFERENCES

• Tubiana M, Chauvel P, Renaud A, Malaise EP. Vitesse de croissance et histoire naturelle du cancer du sein. Bull Cancer (Paris) 1975; 62: 341–58.
   PubMedGoogle Scholar
• Tubiana M. The growth and progression of human tumors. Implications for management strategy. Radiother Oncol 1986; 6: 167–84.
   PubMed Web of Science ®Google Scholar
• Koscielny S, Tubiana M, Le MG, et al. Breast cancer: rela-tionship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 1984; 49: 709–15.
   PubMed Web of Science ®Google Scholar
• Koscielny S, Tubiana M, Valleron AJ. A simulation model of the natural history of human breast cancer. Br J Cancer 1985; 58: 515–24.
   Google Scholar
• Koscielny S, Le MG, Tubiana M. The natural history of breast cancer: the relationship between involvement of axil-lary lymph nodes and the initiation of distant metastases. Br J Cancer 1989; 59: 775–82.
   Google Scholar
• Koscielny S, Tubiana M. The link between local recurrence and distant metastases in human breast cancer. Int .1- Radiat Oncol Biol Phys. In press.
   Google Scholar
• Tubiana M, Koscielny S. Natural history of human breast cancer: recent data and clinical implications. Breast Cancer Res 1991; 18: 125–40.
   Google Scholar
• Tabar L, Fagerberg G, Day NE, et al. Breast cancer treat-ment and natural history: new insights from results of screen-ing. Lancet 1992; 339: 412–4.
   PubMed Web of Science ®Google Scholar
• Meyer JS, Wittliff JL. Regional heterogeneity in breast car-cinoma: thymidine labelling index, steroid hormone receptors. Int .1- Cancer 1991; 47: 213–20.
   PubMed Web of Science ®Google Scholar
• Carter CL, Allen C, Herson DE. Relation of tumor size, lymph node status and survival in 24740 breast cancer cases. Cancer 1989; 63: 181–7.
   Google Scholar
• Handley RS. Observations and thoughts on cancer of the breast. Proc R Soc Med 1972; 65: 437–44.
   PubMedGoogle Scholar
• Ponten J. Natural history of breast cancer. Acta Oncol 1990; 29: 325–34.
   PubMed Web of Science ®Google Scholar
• Slack NH, Blumenson LE, Bross IDJ. Therapeutic implica-tions of a mathematical model characterizing the course of breast cancer. Cancer 1969; 24: 960–71.
   Google Scholar
• Charbit A, Malaise EP, Tubiana M. Relation between the pathological nature and the growth rate of human tumors. Eur J Cancer 1971; 7: 307–15.
   Google Scholar
• Tubiana M. Tumor cell proliferation kinetics and tumor growth rate. Acta Oncol 1989; 28: 111–21.
   Google Scholar
• Tubiana M, Courdi A. Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemina-tion and long term survival. Radiother Oncol 1989; 15: 1–18.
   PubMedGoogle Scholar
• Tubiana M, Pejovic MH, Koscielny S, Chavaudra N, Malaise E. Growth rate, kinetics of tumor cell proliferation, and long-term outcome in human breast cancer. Int .1- Cancer 1989; 44: 17–22.
   Google Scholar
• Lacour J, Le MG, Mouriesse H, et al. It is useful to remove internal mammary nodes in operable breast cancer patients. Eur J Surg Oncol 1987; 13: 309–14.
   PubMedGoogle Scholar
• Kamby C, Andersen J, Ejlertsen B, et al. Pattern of spread and progression in relation to the characteristics of the pri-mary tumour in human breast cancer. Acta Oncol 1991; 30: 301–8.
   PubMed Web of Science ®Google Scholar
• Tubiana M, Sarrazin D. The role of post-operative radiother-apy in breast cancer. In: Ariel JM, Cleary JB, eds. Breast cancer: diagnosis and treatment. New York: McGraw Hill, 1987: 280–99.
   Google Scholar
• Anderson P, Dische S. Local tumor control and the subse-quent incidence of distant metastatic disease. Int .1- Radiat Oncol Biol Phys 1981; 7: 1645–8.
   PubMedGoogle Scholar
• Arriagada R, Le MG, Mouriesse H, et al. Long-term effect of internal mammary chain treatment: results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes. Radiother Oncol 1988; 11: 213–22.
   PubMed Web of Science ®Google Scholar
• Arriagada R, Rutqvist LE, Mattsson A, et al. Adequate loco-regional treatment of early breast cancer may prevent secondary dissemination. J Clin Oncol 1995; 13: 2869–78.
   PubMed Web of Science ®Google Scholar
• Auquier A, Rutqvist LE, Host H, Rotstein S, Arriagada R. Post-mastectomy megavoltage radiotherapy: the Oslo and Stockholm trials. Eur J Cancer 1992; 28: 433–7.
   Google Scholar
• Fuks Z, Leibel SA, Wallner KE, et al. The effect of local control on metastatic dissemination in carcinoma of the prostate: long term results in patients treated with I 125 implantation. Int .1- Radiat Oncol Biol Phys 1991; 21: 537–47.
   PubMed Web of Science ®Google Scholar
• Le MG, Arriagada R, de Vathaire F, et al. Can internal mammary chain treatment decrease the risk of death for patients with medial breast cancers and positive axillary nodes? Cancer 1990; 66: 2313–8.
   PubMedGoogle Scholar
• Leibel SA, Ling CC, Kutcher GJ, et al. The biological basis for conformal three dimensional radiation therapy. Int .1-Radiat Oncol Biol Phys 1991; 21: 805–11.
   PubMed Web of Science ®Google Scholar
• Leibel SA, Scott CB, Mohinddin M, et al. The effect of loco-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG database. Int .1- Radiat Oncol Biol Phys 1991; 21: 549–56.
   PubMed Web of Science ®Google Scholar
• Tubiana M, Arriagada R, Sarrazin D. Human cancer natural history, radiation induced immunodepression and post-opera-tive radiation therapy. Int .1- Radiat Oncol Biol Phys 1986; 12: 477–85.
   Google Scholar
• Tubiana M. Post-operative radiotherapy and the pattern of distant spread. In: Fletcher GH, Levitt SH, eds. Non-dissem-inated breast cancer. Controversial issues in management. Berlin: Springer-Verlag, 1993: 11–26.
   Google Scholar
• Levitt SH, Fletcher GH. Trials and tribulations: do clinical trials prove that irradiation increases cardiac and secondary cancer mortality in the breast cancer patient? Int .1- Radiat Oncol Biol Phys 1991; 20: 523–7.
   Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 1995; 333: 1444–55.
   Google Scholar
• Fisher B. Laboratory and clinical research in breast cancer. A personal adventure. Cancer Res 1980; 40: 3863–74.
   Google Scholar
• Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 1991; 338: 327–31.
   PubMed Web of Science ®Google Scholar
• Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized trial comparing total mastectomy with lumpectomy with or with-out irradiation in the treatment of breast cancer. N Engl J Med 1995; 333: 1456–61.
   PubMed Web of Science ®Google Scholar
• Tubiana M, Sarrazin D. A reappraisal of radiotherapy in the treatment of operable breast cancer: new light on the internal mammary chain role. In: Mouridsen HT, Palshof T, eds. Breast cancer: experimental and clinical aspects. Oxford: Pergamon, 1980: 243–9.
   Google Scholar
• Einhorn J. Loco-regional therapy in breast cancer: the Stock-holm trials-Update. Int .1- Radiat Oncol Biol Phys 1991; (Suppl 21): 107–8.
   Google Scholar
• Rutqvist LE, Cenark B, Glas U, et al. Radiotherapy, chemotherapy, tamoxifen as adjuncts to surgery in early breast cancer: a summary of three randomized trials. Int .1-Radiat Oncol Biol Phys 1989; 16: 629–39.
   PubMed Web of Science ®Google Scholar
• Strender LE, Wallgren A, Arndt J, et al. Adjuvant radiother-apy in operable breast cancer: correlation between dose in internal mammary nodes and prognosis. Int .1- Radiat Oncol Biol Phys 1981; 1: 1319–25.
   Google Scholar
• Wallgren A, Amer O, Bergstrom J, et al. Radiation therapy in operable breast cancer. Results from the Stockholm trial on adjuvant radiotherapy. Int .1- Radiat Oncol Biol Phys 1986; 12: 533–7.
   PubMedGoogle Scholar
• Overgaard M, Christensen JJ, Rose C, et al. Post-mastec-tomy irradiation in high risk breast cancer. Acta Oncol 1988; 27: 707–14.
   PubMed Web of Science ®Google Scholar
• Overgaard M, Hansen PS, Overgaard J, et al. Preoperative radiotherapy in high-risk premonopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997; 337: 949–55.
   PubMed Web of Science ®Google Scholar
• Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337: 956–62.
   PubMed Web of Science ®Google Scholar
• Chauvet B, Reynaud-Bougnoux A, Calais G, Panel N, Lansac J, Bougnoux P. Prognostic factors of breast recurrence in the conservative management of early breast cancer. Int J Radiat Oncol Biol Phys 1990; 19: 1125 —30.
   PubMedGoogle Scholar
• Hellman S. Stopping metastases at their source. N Engl J Med 1997; 337: 966.
   Google Scholar
• Tubiana M, Koscielny S. Natural history of breast cancer: implications for a screening strategy. Int J Radiat Oncol Biol Phys 1990; 19: 1117–20.
   PubMedGoogle Scholar
• Jacquemien J, Eisinger F, Birnbaum D, Sobol H. Histo-prognostic grade in BRCA-1 associated breast cancer. Lancet 1995; 345: 1503.
   Google Scholar
• Eisinger F, Stoppa-Lyonnet D, Longey H, et al. Germ line mutation at BRCA-1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res 1996; 56: 471–4.
   PubMed Web of Science ®Google Scholar